Glomerulosclerosis: the role of interstitial myofibroblasts in its progression

Affiliations

Review

M el Nahas et al. Curr Top Pathol. 1999.

. 1999:93:167-71.

doi: 10.1007/978-3-642-58456-5_17.

No abstract available

Similar articles

Myofibroblasts and the progression of crescentic glomerulonephritis.
Goumenos D, Tsomi K, Iatrou C, Oldroyd S, Sungur A, Papaioannides D, Moustakas G, Ziroyannis P, Mountokalakis T, El Nahas AM. Goumenos D, et al. Nephrol Dial Transplant. 1998 Jul;13(7):1652-61. doi: 10.1093/ndt/13.7.1652. Nephrol Dial Transplant. 1998. PMID: 9681707
Myofibroblasts and the progression of experimental glomerulonephritis.
Zhang G, Moorhead PJ, el Nahas AM. Zhang G, et al. Exp Nephrol. 1995 Sep-Oct;3(5):308-18. Exp Nephrol. 1995. PMID: 7583053
Interstitial myofibroblasts: predictors of progression in membranous nephropathy.
Roberts IS, Burrows C, Shanks JH, Venning M, McWilliam LJ. Roberts IS, et al. J Clin Pathol. 1997 Feb;50(2):123-7. doi: 10.1136/jcp.50.2.123. J Clin Pathol. 1997. PMID: 9155692 Free PMC article.
Role of myofibroblasts in progressive renal diseases.
Moriyama T, Imai E. Moriyama T, et al. Contrib Nephrol. 2003;139:120-40. doi: 10.1159/000071740. Contrib Nephrol. 2003. PMID: 12854322 Review. No abstract available.
[Interstitial involvement in glomerulonephritis].
Strutz F, Becker V, Müller GA. Strutz F, et al. Internist (Berl). 1996 Nov;37(11):1143-51. Internist (Berl). 1996. PMID: 9036110 Review. German. No abstract available.

Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M, Kothapally J, Mao H, Tolbert E, Ponnusamy M, Chin YE, Zhuang S. Pang M, et al. Am J Physiol Renal Physiol. 2009 Oct;297(4):F996-F1005. doi: 10.1152/ajprenal.00282.2009. Epub 2009 Jul 29. Am J Physiol Renal Physiol. 2009. PMID: 19640900 Free PMC article.